ImmUniverse partner ITTM participating in IHI webinar

Small and medium-sized enterprises (SMEs) are key players in the European pharmaceutical research and development landscape. In projects of the Innovative Health Initiative (IHI), SMEs act as a key interface between the latest academic discoveries and implementation in industry. ImmUniverse partner ITTM had the honour to contribute to a recent webinar addressing the question “How do IMI projects facilitate the participation and growth of SMEs?”

The IHI Programme Officer Colm Carroll guided the insightful discussions in which Julia Kurps (HYVE), Mathieu Galtier (Owkin) and Andreas Kremer (ITTM) shared their experience.

More information about the event and the slides presented during the discussion can be found here.